BG Medicine and Boston Scientific partner to investigate galectin-3 as an aid in patient screening for cardiac-resynchronization therapy (CRT)

BG Medicine Inc.

U.S. / Medical Devices and Diagnostics

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Boston Scientific Corp.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced